The Director's Forum series is written and edited by Michael Sanborn and Robert Weber and is designed for guiding pharmacy leaders in establishing patient-centered services in hospitals and health systems. Another specific goal of this column is addressing many of the key challenges that pharmacy directors currently face, while also providing information that will foster growth in pharmacy leadership and patient safety. Previous Director's Forum articles have discussed various aspects of pharmacy technology implementation and utilization. This feature focuses on the effective integration of smart pump technology to maximize patient safety benefits.
Get full access to this article
View all access options for this article.
References
1.
Proceedings of a summit on preventing patient harm and death from I.V. medication errors. Am J Health Syst Pharm.2008; 65(24): 2367–2379.
2.
PedersenC.A., SchneiderP.J., ScheckelhoffD.J.ASHP national survey of pharmacy practice in hospital settings: dispensing and administration—2005. Am J Health Syst Pharm.2006; 63(4): 327–345.
3.
PedersenC.A., GumperK.F.ASHP national survey on informatics: assessment of the adoption and use of pharmacy informatics in U.S. hospitals—2007. Am J Health Syst Pharm.2008; 65(23): 2244–2264.
LarsenG.Y., ParkerH.B., CashJ., O'ConnellM., GrantM.C.Standard drug concentrations and smart-pump technology reduce continuous-medication-infusion errors in pediatric patients. Pediatrics.2005; 116(1): e21–e25.
6.
MalashockC.M., ShullS.S., GouldD.A.Effect of smart infusion pumps on medication errors related to infusion device programming. Hosp Pharm.2004; 39(5): 460–469.
7.
RothschildJ.M., KeohaneC.A., CookE.F.A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med.2005; 33(3): 533–540.
8.
WilliamsC.K., MaddoxR.R.Implementation of an I.V. medication safety system. Am J Health Syst Pharm.2005; 62(5): 530–536.
9.
AdachiW., LodolceA.E.Use of failure mode and effects analysis in improving the safety of I.V. drug administration. Am J Health Syst Pharm.2005; 62(9): 917–920.
10.
JacobsB.New intravenous pumps help increase safety measures and improve cost-effectiveness. Nurse Manage.2005; 36(12): 40–44.
11.
CassanoA.T.IV medication safety software implementation in a multihospital health system. Hosp Pharm.2006; 41(2): 151–156.
12.
WilliamsC.K., MaddoxR.R., HeapeE., RichardsH.E., GriffithsD.L., CrassR.E.Application of the IV Medication Harm Index to assess the nature of harm averted by “smart” infusion safety systems. J Patient Saf.2006; 2(3): 132–139.
13.
FanikosJ., FiumaraK., BarolettiS.Impact of smart infusion technology on administration of anticoagulant (unfractionated heparin, argatroban, lepirudin, and bivalirudin). Am J Cardiol.2007; 99(7): 1002–1005.
14.
BatesD.W.Preventing medication errors: a summary. Am J Health Syst Pharm.2007; 64(14)(suppl 9): S3–S9.
15.
HessJ., WhitingS.Making an intelligent smart pump purchase. Materials Management in Health Care.www.matmanmag.com. Published August 2007. Accessed February 7, 2009.
Siv-LeeL., MorganL.Implementation of wireless “intelligent” pump IV infusion technology in a not-for-profit academic hospital setting. Hosp Pharm.2007; 42(9): 832–840.
18.
WetterneckT.B., SkibinskiK.A., RobertsT.L.Using failure mode and effects analysis to plan implementation of smart I.V. pump technology. Am J Health Syst Pharm.2006; 63(16): 1528–1538.
19.
CohenM.R., SmetzerJ.L.Lack of standard dosing methods contribute to IV errors. Hosp Pharm.2007; 42(12): 1100–1101.
